New Key Statistics Module, Z-Score and F-Score
NAS:LEXX Key Ratios
| Market Cap $ M | 39.82 |
| Enterprise Value $ M | 27.05 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 5.83 |
| Price/Sales | 57.74 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.68 |
| Beneish M-Score | -1.37 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 16.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.16 |
| EV-to-EBITDA | -5.30 |
| PEG | -- |
| Shares Outstanding M | 12.89 |
| Net Margin (%) | -1,409.33 |
| Operating Margin % | -1,363.21 |
| Pre-tax Margin (%) | -1,417.36 |
| Quick Ratio | 66.06 |
| Current Ratio | 66.06 |
| ROA % (ttm) | -117.45 |
| ROE % (ttm) | -119.95 |
| ROIC % (ttm) | -402.72 |
| Dividend Yield % | -- |
| Altman Z-Score | 80.97 |
LEXX Number of Guru Trades
LEXX Volume of Guru Trades
Gurus Latest Trades with NAS:LEXX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LEXX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lexaria Bioscience Corp Insider Transactions
No Available Data
News about NAS:LEXX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers